Dr. Reddy’s to acquire Nicotinell from Haleon
Dr. Reddy’s Laboratories has announced that its subsidiary Dr. Reddy’s Laboratories SA will acquire Haleon’s global portfolio of consumer healthcare brands in the Nicotine Replacement Therapy (NRT) category outside of the United States through purchase of shares of Northstar Switzerland SARL.